Showing results (51-60 of 96) with videos related to
Sort By:
Pageof 10
Journal of Neuroimmunology|September 15, 2014
Immunological effects of methylprednisolone pulse treatment in progressive multiple sclerosisR Ratzer, J Romme Christensen, B Romme Nielsen, et al.Neurology|March 9, 2005
A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritisH G Roed, A Langkilde, F Sellebjerg, et al.Neurology|December 10, 2009
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MSF Sellebjerg, L Börnsen, M Khademi, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2012
Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosisF Sellebjerg, D Hesse, S Limborg, et al.European Journal of Neurology|February 18, 2009
The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkersM Khademi, L Bornsen, F Rafatnia, et al.European Journal of Neurology|May 29, 2009
EFNS guidelines on disease-specific CSF investigationsF Deisenhammer, R Egg, G Giovannoni, et al.Acta Neurologica Scandinavica|May 15, 2013
The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosisM Møller, H B Søndergaard, N Koch-Henriksen, et al.Journal of Neuroimmunology|March 17, 2004
CD4 T cell activation and disease activity at onset of multiple sclerosisJ Jensen, A R Langkilde, C Fenst, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2013
Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosisR Ratzer, H B Søndergaard, J Romme Christensen, et al.BMC Neurology|August 17, 2021
The association of selected multiple sclerosis symptoms with disability and quality of life: a large Danish self-report surveyS Gustavsen, A Olsson, H B Søndergaard, et al.Pageof 10